Cortical Labs introduces CL1, a biological computer that merges human neurons with digital technology, revolutionizing AI, medical research, and ethical testing methods.
 |
| The CL1 biological computer by Cortical Labs merges living human neurons with silicon technology, paving the way for a new era in AI and medical research. Image: Cortical Labs/ ChicHue |
Barcelona, Spain — March 10, 2025:
Cortical Labs has introduced a groundbreaking innovation at the MWC 2025 in Barcelona: the CL1, a biological computer powered by living human neurons. This revolutionary device merges biology with artificial intelligence, providing a new approach to studying neural behavior, advancing medical research, and offering an ethical alternative to traditional animal testing.
The CL1 sets itself apart from conventional AI models by using real, living human neurons cultivated on a silicon chip. These neurons, kept alive for up to six months using an internal life-support system, interact with a digital environment, forming a dynamic and adaptable network. Researchers can program the neurons in real-time through Cortical Labs’ proprietary Biological Intelligence Operating System (biOS), enabling them to observe how these neurons learn, respond to stimuli, and evolve over time.
This technology offers unprecedented potential for medical research, particularly in understanding neurological disorders such as Alzheimer’s, Parkinson’s, and other cognitive diseases. By directly studying human neurons, CL1 could provide faster, more accurate insights into the effects of drugs and treatments.
Additionally, the CL1 represents a significant ethical advancement in research. By reducing the need for animal testing, it allows scientists to gather human-relevant data, thus addressing growing concerns about the use of animals in scientific studies. The system’s energy-efficient design ensures that it remains sustainable, providing a long-term solution for labs around the world.
Cortical Labs plans to commercialize the CL1 in the second half of 2025, with a price tag of $35,000 per unit. Furthermore, the company is developing a neural network server stack comprising 30 CL1 units, which will be accessible through a cloud-based platform. This setup will enable researchers across the globe to conduct experiments remotely, expanding possibilities for drug discovery, disease modeling, and even robotics.
By bridging the gap between biology and technology, the CL1 opens new doors for both AI and medical research, offering a glimpse into a future where organic and digital systems coexist and work together to solve humanity’s most complex challenges.